Solid Biosciences Inc (NAS:SLDB)
$ 8.53 -0.59 (-6.47%) Market Cap: 327.38 Mil Enterprise Value: 169.77 Mil PE Ratio: 0 PB Ratio: 1.53 GF Score: 40/100

Solid Biosciences Inc at Barclays Virtual Gene Editing & Therapy Summit Transcript

May 24, 2023 / 03:30PM GMT
Release Date Price: $6.01 (-2.91%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Good morning, everyone. My name is Gena Wang. I'm SMID cap biotech analyst at the Barclays. Thank you very much for joining the 7th Gene Editing and Gene Therapy Summit at the Barclays. I would like to first take this opportunity to thank all the investors, companies, also, especially our event team and the corporate access team who made this event possible.

With that, I would like to introduce our next presenting company, Solid. With us today, we have Bo Cumbo, President and Chief Executive Officer. We also have Kevin Tan, Chief Financial Officer. Thank you both for joining us today.

Kevin Tan
Solid Biosciences Inc. - CFO & Treasurer

Thanks for having us.

Alexander G. Cumbo
Solid Biosciences Inc. - President, CEO & Director

Thank you, Gena.

Questions & Answers

Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

So maybe, Bo, I will start with DMD

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot